Thank you for your interest in Tiny Dose, Big Impact: Low Dose Naltrexone (LDN) for Autoimmune Diseases, Chronic Pain and Depression!
Naltrexone, an drug that has been FDA approved for decades to treat alcohol and opioid addiction, is now being used off-label in tiny doses to treat autoimmune disorders, chronic pain and depression. This inexpensive treatment is helping tens of thousands of patients worldwide who have run out of options. Log on and learn about LDN and if it might be right for you.
Register for the webinar on Tuesday, September 15, 2020 at 5:30 p.m. below!